Daniel F. Wyss

Statistics

Publications

Citations

6.6K

H-Index

Active since

1991

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Novartis (Switzerland)

Harvard University

Novartis Institutes for BioMedical Research

Novartis (United Kingdom)

Daniel F. Wyss is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in life sciences, pharmacology, and structural biology.

ORCID

Publications per year

1991–2023

Publications

High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response

Hui Gao, Joshua M. Korn, Stéphane Ferretti et al. · Nature Medicine · 2015 · 1.4K citations

Medicine, Oncology, Pharmacology +12

Anterior Femoroacetabular Impingement

Martín Beck, Michael Leunig, Javad Parvizi et al. · Clinical Orthopaedics and Related Research · 2004 · 856 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +15

An orally available non-nucleotide STING agonist with antitumor activity

Bo‐Sheng Pan, Samanthi A. Perera, Jennifer Piesvaux et al. · Science · 2020 · 660 citations

Medicine, Medicinal Chemistry, Pharmacology +16

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

Viviana Galimberti, Bernard F. Cole, Giuseppe Viale et al. · The Lancet Oncology · 2018 · 565 citations

Medicine, Oncology, Surgery +17

Conformation and Function of the N-Linked Glycan in the Adhesion Domain of Human CD2

Daniel F. Wyss, Johnathan S. Choi, Jing Li et al. · Science · 1995 · 310 citations

Life Sciences, Biochemistry, Molecular Biology +17

1–5 of 49